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Abstract 
Background: Alterations in the structure and physiology of interneurons in the prefrontal cortex (PFC) are important 
factors in the etiopathology of different psychiatric disorders. Among the interneuronal subpopulations, parvalbumin 
(PV) expressing cells appear to be specially affected. Interestingly, during development and adulthood the connectiv‑
ity of these interneurons is regulated by the presence of perineuronal nets (PNNs), specialized regions of the extracel‑
lular matrix, which are frequently surrounding PV expressing neurons. Previous reports have found anomalies in the 
density of PNNs in the PFC of schizophrenic patients. However, although some studies have described alterations in 
PNNs in some extracortical regions of bipolar disorder patients, there are no studies focusing on the prefrontocortical 
PNNs of bipolar or major depression patients. For this reason, we have analyzed the density of PNNs in post‑mortem 
sections of the dorsolateral PFC (DLPFC) from the Stanley Neuropathology Consortium, which includes controls, 
schizophrenia, bipolar and major depression patients.
Results: We have not observed differences in the distribution of PV+ cells or PNNs, or in the percentage of PV+ 
interneurons surrounded by PNNs. The density of PV+ interneurons was similar in all the experimental groups, but 
there was a significantly lower density of PNNs in the DLPFC of bipolar disorder patients and a tendency towards a 
decrease in schizophrenic patients. No differences were found when evaluating the density of PV+ cells surrounded 
by PNNs. Interestingly, when assessing the influence of demographic data, we found an inverse correlation between 
the density of PNNs and the presence of psychosis.
Conclusions: The present results point to prefrontocortical PNNs and their role in the regulation of neuronal plas‑
ticity as putative players in the etiopathology of bipolar disorder and schizophrenia. Our findings also suggest a link 
between these specialized regions of the extracellular matrix and the presence of psychosis.
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Background
Psychiatric disorders affect 1 out of 4 people at some 
point during their lives and represent a huge economic 
and social burden (World Health Organization 2001). 
However, the neuronal mechanisms underlying the 
development of these diseases still remain unclear, 
highlighting the need for further research in basic neu-
roscience. Bipolar disorder, major depression or schizo-
phrenia are very different pathologies, but they share 
certain structural and functional abnormalities, including 
alterations in the inhibitory networks of the prefrontal 
cortex (PFC).
These alterations are especially pronounced in the PFC 
of schizophrenia and bipolar disorder patients, where 
reductions of GAD67, one of the enzymes responsible 
for GABA synthesis, have been described (Akbarian et al. 
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1995; Guidotti et al. 2000). There is also evidence of the 
involvement of the prefrontocortical GABAergic system 
in major depression: patients show reduced GABA levels 
(Hasler et al. 2007) and decreased expression of GABAe-
rgic genes (Zhao et  al. 2018). Moreover, schizophrenic 
patients display altered expression of GABA-related 
genes in their PFC, such as transporters or receptors of 
this neurotransmitter (Benes et al. 1996; Hashimoto et al. 
2008; Hoftman et al. 2015; Volk et al. 2001).
Parvalbumin (PV) expressing interneurons constitute 
one of the three families of cortical interneurons fol-
lowing a classification by their calcium-binding protein 
expression. PV expressing interneurons effectively syn-
chronize large populations of neurons, regulating the 
synaptic excitatory tone in different cortical regions (Hu 
et  al. 2014). Furthermore, alterations in this subpopula-
tion of interneurons have been described in different 
psychiatric diseases, such as major depression, schizo-
phrenia, autism or bipolar disorder (Marín 2012). In the 
PFC of bipolar disorder patients there is a reduction in 
the expression of PV mRNA (Sibille et  al. 2011). Simi-
larly, in schizophrenic patients there is a reduction in the 
expression of GAD67 mRNA, specifically in PV express-
ing cells (Hashimoto et  al. 2003) and these alterations 
have been related to abnormalities in the synaptic input 
that PV expressing interneurons establish onto pyramidal 
cells (Lewis et al. 2012). Although some studies on major 
depression patients have not found changes in PV expres-
sion or in PV+ cell density in the PFC (Beasley et  al. 
2002; Rajkowska et  al. 2007; Sibille et  al. 2011), at least 
one found a decrease in PV gene expression (Tripp et al. 
2012). Similarly, anomalies in PV expressing interneu-
rons have been also reported in animal models of major 
depression (Perova et al. 2015; Pesarico et al. 2019; Sauer 
et al. 2015; Todorovic et al. 2019).
Alterations of prefrontocortical PV expressing 
interneurons are likely to be mediated by the expres-
sion of molecules related to interneuronal plasticity. 
Known regulators of the structure and connectivity of 
PV expressing interneurons include the polysialylated 
form of the neural cell adhesion molecule (PSA-NCAM) 
(Nacher et al. 2013). In fact, we have described a reduced 
expression of PSA-NCAM in layers IV and V of the PFC 
of schizophrenic patients (Gilabert-Juan et al. 2012).
Other important regulators of interneuronal plasticity 
and particularly of PV expressing interneurons are the 
perineuronal nets (PNNs), specialized structures of the 
extracellular matrix, which predominantly surround the 
soma and proximal neurites of PV expressing interneu-
rons (Sorg et  al. 2016). PNNs are composed by hyalu-
ronic acid, tenascin-R, link proteins and proteoglycans 
(mainly chondroitin sulphate proteoglycans) (Kwok et al. 
2011). Although the functions of PNNs are not clear yet, 
it is known that they mediate the closure of the critical 
periods of cortical plasticity through the stabilization 
of recently formed synapses and the prevention of syn-
aptogenesis (McRae and Porter 2012; Pizzorusso et  al. 
2002; Wang and Fawcett 2012). PNNs are also impor-
tant to maintain the local homeostasis of ions (Moraw-
ski et al. 2015) and to protect neurons against oxidative 
stress (Cabungcal et al. 2013). Particularly, PNNs control 
the activity and excitability of PV expressing neurons 
(Balmer 2016; Dityatev et al. 2007; Favuzzi et al. 2017). In 
fact, the enzymatic attenuation of PNNs alters the excita-
tory input to fast-spiking PV expressing interneurons 
(Hayani et  al. 2018). Moreover, alterations in the glyco-
protein tenascin-R, a key component of the PNNs, which 
helps in the stabilization of these regions of the extracel-
lular matrix, impairs the perisomatic inhibitory input to 
pyramidal neurons (Saghatelyan et al. 2000, 2001, 2003).
Interestingly, abnormalities of chondroitin sulfate 
proteoglycans have been implicated in the etiopathol-
ogy of different psychiatric disorders (Berretta 2012). 
In this line, some studies have shown that subjects with 
schizophrenia had a reduced density of PNNs in the PFC 
(Enwright et  al. 2016; Mauney et  al. 2013) and similar 
reductions have been found in different animal models of 
this disorder (Castillo-Gómez et al. 2017; Matuszko et al. 
2017; Paylor et al. 2016). Although there are some reports 
describing alterations in PNNs in certain extracortical 
regions of bipolar disorder patients (Pantazopoulos et al. 
2010; Steullet et al. 2018), to our knowledge there are no 
studies to date focusing on the PFC of bipolar disorder or 
major depression patients.
In this study, we investigated whether the densities of 
PV expressing interneurons and PNNs were affected in 
the DLPFC of individuals suffering from major depres-
sion, schizophrenia or bipolar disorder. We have selected 
this prefrontocortical region because structural and 
functional alterations have already been found in these 
diseases (Phillips et  al. 2003). Moreover, previous stud-
ies in the DLPFC, including our own (Gilabert-Juan et al. 
2012), have found changes in molecules related to inhibi-
tory neurotransmission and in PV+ cells and PNNs, spe-
cifically in Brodmann area 9 (BA9). We have performed 
histochemical analysis in brain sections from post-mor-
tem samples of psychiatric patients and a control group 
and have measured the density of PV and PNN positive 
cells and their co-localization.
Methods
Samples and histological processing
Frozen 14 µm thick coronal sections containing the dor-
solateral prefrontal cortex (DLPFC) of patients diagnosed 
with major depression, bipolar disorder or schizophre-
nia, and control subjects were obtained from the Stanley 
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Medical Research Institute (Bethesda, MD, USA). All 
patient records were reviewed by one psychiatrist and 
summarized in narrative form, and the information was 
entered into a computerized database by identifying 
number only. When all the information was collected, a 
DSM-IV psychiatric diagnosis was made independently 
by two senior psychiatrists. If there was disagreement 
between them, the records were given to a third senior 
psychiatrist and a consensus diagnosis was established 
(Torrey et al. 2000). The cohort consists of 15 individuals 
in each group, although some samples were not analyzed 
due to the poor condition of the tissue. The demographic 
and recruitment data of patients have been described 
earlier (Gilabert-Juan et al. 2012) and are summarized in 
Table 1. All brains underwent clinical neuropathological 
examination by two neuropathologists, none demon-
strated evidence of neurodegenerative changes or other 
pathological lesions.
Sections were thawed and immediately fixed by immer-
sion in a solution of paraformaldehyde 4% during 20 min. 
After fixation, sections were washed in phosphate buffer 
(PB: 0.1  M, pH 7.4) and processed immediately for 
immunohistochemistry. All the sections studied passed 
through the procedures simultaneously, to minimize 
any difference from the immunohistochemical protocols 
themselves. Experimenters were blind to the experimen-
tal condition until the end of the quantification.
Histochemistry
Tissue was processed for fluorescence histochemistry as 
follows. After PB washing, slices were incubated in 10% 
normal donkey serum (NDS), 0.2% Triton-X100 (Sigma) 
in phosphate buffered saline (PBS) for 1  h. Then, slices 
were washed again in PBS and incubated for 48 h at 4 °C 
with polyclonal guinea pig anti-PV antibody (1:2000, 
Synaptic Systems, Gottingen, Germany) and biotin-
conjugated Wisteria floribunda agglutinin (WFA, 1:200, 
Sigma) diluted in PBS 0.2% Triton-X100. After washing 
with PBS, sections were incubated at room temperature 
for 2  h with the secondary antibody: A555-conjugated 
goat anti-guinea pig (1:400, LifeTechnologies, Carlsbad, 
CA, USA) and A647-conjugated streptavidin (1:400, 
LifeTechnologies, Carlsbad, CA, USA), both diluted in 
PBS 0.2% Triton-X100. Finally, sections were washed in 
PB, mounted on slides and coverslipped using fluores-
cence mounting medium (Dako, Glostrup, Denmark).
Confocal microscopy and image analyses
In order to analyze the densities of both PV positive 
interneurons and PNNs, single confocal planes were 
obtained using a laser scanning confocal microscope 
(Leica TCS SPE) and images were processed with FIJI 
(ImageJ, NIH). We analyzed three images of 275.17 μm2 
from each patient, taken randomly in the deep layers of 
the DLPFC (layers III, IV, V and VI). In order to obtain 
these images, we delimited the total area containing the 
deep layers of the DLPFC and selected three squares of 
275.17  μm2, which generated with random coordinates 
within this area. During this procedure we excluded the 
squares with areas that were partially outside the delim-
ited region. This procedure was used for every patient 
and experimental group. PV expressing interneurons and 
PNNs were counted in all three images and their density 
was calculated as neurons/area.
Statistical analyses
Group differences were assessed using a one-way 
ANOVA and multiple comparisons p-value adjustment 
by Bonferroni post hoc analysis. We first performed a 
Bartlett’s test to assess the homoscedasticity of the data 
and Shapiro test for normality. No p-value was found 
to be statistically significant, thus, we were able to per-
form parametric tests such as ANOVA. Analyses were 
performed with R version 3.6.1 (R Core Team 2019). and 
Table 1 Clinical and demographical data of the Stanley Foundation Neuropathology Consortium
Control MD BD SCHZ
n 11 11 13 10
Age, years, mean (SEM), (range) 46.6 (29–59) 48 (32–65) 42.9 (25–57) 43.5 (25–62)
Sex male/female 4/7 5/6 5/8 5/5
PMI, hours, mean (SEM), (range) 26 (8–42) 25.8 (7–47) 31.5 (13–62) 35.4 (12–60)
Tissue pH, mean (SEM), (range) 6.3 (5.8–6.6) 6.2 (5.8–6.5) 6.2 (5.8–6.5) 6.2 (5.8–6.6)
Suicide 0 4 8 3
Alcohol use 7 7 9 6
Psychosis 0 0 10 10
Brain weight, g, mean (SEM), (range) 1529.5 (1305–1840) 1439.1 (1240–1740) 1444.5 (1130–1690) 1465 (1270–1640)
Duration, years, mean (SEM), (range) 13.4 (2–42) 19 (6–43) 22.1 (5–45)
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graphs created using GraphPad Prism 6. All values are 
expressed as mean ± standard error of the mean (SEM). 
The cutoff for statistical significance was set as p = 0.05. 
Effect of post-mortem interval (PMI), brain pH, brain 
weight, age, gender, suicide, substance/alcohol abuse, 
presence of psychosis, side of the brain (right or left hem-
isphere), age of disease onset or lifetime neuroleptic use 
(in fluphenazine mg equivalents) was assessed by uni-
variable and multivariable analyses. First, we performed 
a model for each variable in the data base: categorical 
variables were analyzed by one-way ANOVA (age, sex, 
suicide, alcohol abuse, presence of psychosis, side of the 
brain), continuous variables (age, brain pH, brain weight, 
PMI, age of disease onset or lifetime neuroleptic use) 
were analyzed by simple linear regression analysis. Sec-
ond, we performed a multivariable analysis, searching for 
models that could integrate all the variables. For devel-
oping the models, we used the glmulti library (Calcagno 
2018). The method for the selection of the best model has 
been based on the Akaike Information Criterion (Saka-
moto et  al. 1986). Since the model includes categorical 
and continuous variables and a continuous variable as 
dependent variable we used an analysis of covariance 
(ANCOVA).
Results
Distribution of PNNs and PV expressing cells in the DLPFC
Although PNNs could be observed in all the extension of 
the DLPFC, we found a differential distribution among 
layers. In layer I we found virtually no PNNs. A low PNN 
density was found in layers II and IV. Layers V and VI had 
an intermediate density of PNNs and the highest PNN 
density was found in layer III.
The distribution of PV positive cells was, as expected, 
similar to that of PNNs (Fig. 1a). The highest density of 
PV positive cells was found in layers III and IV, followed 
by those in layers II and V. We found the lower density of 
cells in layers I and VI.
We performed all our analyses in deep layers of the 
DLPFC, including layers III, IV, V and VI. The percent-
ages of PNNs surrounding PV+ somata were around 
75% in every group and no significant differences were 
found between them (controls: 69.3 ± 6.7%; schizophre-
nia: 78.6 ± 8.5%; bipolar: 76.64 ± 5.4%; major depression: 
74.2 ± 5,4%; F(3, 35) = 0.3965, p = 0.7563). Interestingly, 
some of the PV negative somata surrounded by PNN had 
the typical morphology of pyramidal neurons.
Bipolar individuals show a lower PNN density in the DLPFC
We compared the density of both PNNs and PV immu-
noreactive neurons in the DLPFC of patient and control 
groups (Fig. 1b). One way-ANOVA analysis showed that 
there were no differences in the density of PV expressing 
interneurons between the four groups (F(3, 34) = 0.4334, 
p = 0.8099; Fig. 1c).
When analyzing the density of PNNs, we found signifi-
cant differences in PNN density between the four groups 
(F(3, 38) = 3.581, p = 0.0225). Bonferroni’s post hoc 
analysis showed a significantly lower density of PNNs in 
patients suffering from bipolar disorder compared to the 
control group (F(3, 38) = 3.581, p = 0.012). We also found 
a tendency towards a lower density of PNNs in schizo-
phrenic patients compared to the control group (F(3, 
38) = 3.581, p = 0.0643; Fig. 1d).
Finally, we analyzed in the four groups the percentages 
of PV expressing interneurons surrounded by PNNs (F(3, 
36) = 1.586, p = 0.1193; Fig. 1e), of PNNs surrounding PV 
expressing interneurons (F(3, 35) = 0.3965, p = 0.7563; 
Fig.  1f ) and of PNNs not associated with PV+ somata 
(F(3, 35) = 0.3965, p = 0.7563; Fig.  1g). We did not find 
any significant difference between groups in any of these 
parameters.
Patients with psychosis show a lower density of PNNs
We performed univariable and multivariable analyses 
to assess the influence of demographic data (age, sex, 
PMI, weight of the brain…) on our experimental con-
ditions (see “Methods” section). We only observed an 
effect of the presence of psychosis: patients who had 
suffered psychotic episodes had lower PNN density 
(Fig. 2). This significant difference was found both using 
univariable (Pr(> F) = 0.034) and multivariable analyses 
(Pr(> |t|) = 0.035).
Discussion
The present study compares the densities of PNNs and 
PV expressing neurons in the DLPFC of patients suf-
fering from three different neuropsychiatric disorders 
(major depression, bipolar disorder and schizophrenia) 
and healthy individuals.
The distribution of PNNs and PV expressing cells in 
the DLPFC did not differ among the four groups of our 
study and it was very similar to that described before in 
this region (Brodmann area [BA] 9) (Beasley et al. 2002; 
Enwright et al. 2016; Hashimoto et al. 2003; Mauney et al. 
2013; Sakai 2008). The study of Enwright et al. (2016) was 
focused in layer III, where, in accordance with our results, 
most of PV+ cells and PNNs are located, but in our pre-
sent study we have also included in the analysis layers IV, 
V and VI. In consonance with this previous study on PV+ 
cells and PNNs in the DLPFC of schizophrenic patients, 
we have also observed that, although many PV+ cells 
were surrounded by PNNs, some of them (around a 25%) 
were devoid of these specialized extracellular matrix 
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structures. Interestingly, no differences in this percent-
age were detected among the different groups analyzed. 
It is possible that we have failed to detect a subpopulation 
of PV+ cells with low levels of expression of this calcium 
binding protein. In fact, it has been described that, in the 
human DLPFC, PV+ cells surrounded by PNNs have 
lower immunoreactivity than those lacking these struc-
tures (Enwright et al. 2016). Some of the PNNs that were 
not surrounding PV+ interneurons had the typical mor-
phology of pyramidal neurons, suggesting, as described 
before (Enwright et  al. 2016), that a subpopulation of 
excitatory neurons is also enwrapped by PNNs. This is 
relevant for our study, since the differences in the density 
of PNNs that we have detected are not reflected in dif-
ferences in the density of PNN specifically surrounding 
PV+ somata. Unfortunately, very little is known about 
the impact of PNN coverage on pyramidal neurons.
Regarding the density of PNNs, we have observed 
a trend towards a decrease in schizophrenic patients, 
which reaches significance if a less restrictive post hoc 
test is applied. This result is similar, although less dra-
matic, than that obtained by Mauney et  al. (2013), who 
found a 70% reduction in this parameter. It is interesting 
to note that these authors improved substantially their 
Fig. 1 Alterations of PV and PNN densities in neuropsychiatric disorders. a Panoramic confocal microphotograph showing WFA‑labeled PNNs (blue) 
surrounding PV positive somata (red) in the deep layers of the dorsolateral prefrontal cortex (DLPFC) of a control individual. b Images of single 
confocal planes showing PNNs surrounding PV+ somata in the DLPFC in patients suffering from major depression (MD), bipolar disorder (BD) and 
schizophrenia (SCHZ) and controls (NOR). White arrowheads point to PV+ somata surrounded by PNNs, yellow arrowheads point to PV+ cells 
lacking PNNs and white arrows point to PNNs surrounding PV− somata. c–g Histograms showing the density of PV expressing interneurons (c), 
PNNs (d) and the percentages of PV expressing somata surrounded by PNNs (e), of PNNs surrounding PV+ somata (f) and of PNNs not surrounding 
PV+ somata (g). There are significant differences in the density of PNN between control individuals and bipolar patients (*p = 0.012). Scale bar: 
20 µm
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PNN labeling when using sections from frozen samples 
and then postfixing them, as we have done in the present 
study. In a more recent study, Enwright et al. (2016) did 
not find changes in PNN density, but detected reduced 
intensities of fluorescence for PNNs markers. These 
results are in consonance with previous results, including 
our own, in mouse models of schizophrenia, which have 
found reductions in the number of PNNs in the medial 
PFC (Castillo-Gómez et  al. 2017; Matuszko et  al. 2017; 
Paylor et al. 2016).
To our knowledge only other report has studied the 
PNNs in the DLPFC of bipolar disorder patients and it 
did not find differences in their density (Mauney et  al. 
2013). This is apparently in contrast with our results, 
but this discrepancy may arise from the methodology 
employed to process the samples. Mauney et  al. (2013) 
used fixed blocks of tissue to obtain their sections, while 
we have used sections obtained from frozen blocks 
and have postfixed them subsequently. This procedure 
improves dramatically the sensibility of the detection of 
PNNs, as described by the same authors (Mauney et al. 
2013). Our results are in consonance with a recent study 
performed in the reticular thalamic nucleus, which has 
found decreases in the number of PNNs both in schizo-
phrenic and bipolar patients (Steullet et al. 2018).
Our study is the first to have explored the presence of 
changes in the density of PNNs in the DLPFC of major 
depression patients, finding negative results. How-
ever, more studies need to be performed with different 
and larger samples of patients to discard an impact of 
major depression on PNNs. In fact, animals subjected to 
chronic stress, a model of depression, during the adoles-
cence or during adulthood show alterations in the num-
ber of PNNs (Castillo-Gómez et al. 2017; de Araújo Costa 
Folha et al. 2017; Pesarico et al. 2019).
In consonance with a previous study on the BA9 of 
the DLPFC, which used the same collection of sam-
ples that we have analyzed in the present study (Beasley 
et  al. 2002), we have not found differences in the den-
sity of PV immunoreactive somata in any of the patient 
groups. Woo et  al. (1997) also failed to find differences 
in the density of PV+ interneurons in the BA9 of schizo-
phrenic patients. It has to be noted, however, that other 
study found this density reduced in BA10 (Beasley and 
Reynolds 1997). Sakai (2008) also found differences in 
PV+ somata density in BA9 of schizophrenic patients, 
but only in layer IV, where their density is relatively low. 
A more recent study (Enwright et al. 2016) has not found 
significant differences in the density of PV+ cells in the 
layer III of BA9 of schizophrenic patients, although they 
discovered that the intensity of PV immunolabeling was 
lower in these patients than in controls. This is also in 
accordance with the reduced expression of PV mRNA in 
layers III and IV in BA9 (Hashimoto et al. 2003).
Our negative results concerning the density of PV+ 
cells in the DLPFC of bipolar patients are confirmatory of 
those obtained before in BA9 using immunohistochemis-
try and in situ hybridization (Beasley et al. 2002; Bitani-
hirwe et  al. 2010; Sakai 2008). However, a study in this 
area using real-time quantitative PCR found a decrease in 
PV mRNA (Sibille et al. 2011).
Fig. 2 Effects of psychosis on the density of PNNs. a Confocal images, showing WFA‑labeled PNNs (blue) surrounding PV positive somata (red) in 
the dorsolateral prefrontal cortex (DLPFC) of patients diagnosed with (a2) and without (a1) psychosis. b Histogram comparing the density of PNNs 
in individuals diagnosed with (black bar) or without (white bar) psychosis (Pr(> F) = 0.034; Pr(> |t|) = 0.035). Scale bar: 20 µm
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We have also failed to find significant differences in the 
density of PV+ cells in the DLPFC of major depression 
patients. Similar results were found in previous reports 
studying the density of PV+ somata (Beasley et al. 2002; 
Rajkowska et  al. 2007) or the expression of PV mRNA 
(Sibille et  al. 2011). Khundakar et  al. (2011) reported a 
decrease in the density of PV+ cells in layer III of BA9, 
but this study was performed in a sample of elderly major 
depression patients; the mean age of the group studied in 
the present report is younger (48 years).
To assess the influence of the demographic data on our 
results, we performed univariable and multivariable anal-
yses (see “Methods” section). We report here for the first 
time that patients who had suffered psychotic episodes 
had lower PNN density. Since all of our schizophrenic 
patients and most of bipolar disorder patients presented 
psychosis during their life, we think that the lower den-
sity of PNNs may be related to the presence of psychosis 
per se.
Since PNNs appear to have a protective role against 
oxidative stress in PV expressing interneurons (Cabung-
cal et al. 2013), the decrease in PNN density that we have 
reported in psychotic individuals could be related to an 
increase in oxidative stress. In fact, increases in oxidative 
stress have been described in the brain of both SCHZ and 
BD patients (Andreazza et  al. 2008; Yao and Keshavan 
2011). Moreover, similar to what we have observed with 
PNNs, a previous study on the expression of reelin, an 
extracellular matrix protein, reported a downregulation 
in psychotic bipolar and schizophrenic patients when 
compared to control individuals and bipolar patients 
without psychosis (Guidotti et al. 2000). Interestingly, the 
presence of psychosis has been linked to abnormalities in 
gamma band oscillations (McNally and McCarley 2016) 
and on PV+ interneuron function (Sohal et al. 2009).
Conclusion
The link between psychosis, interneurons and PNNs has 
to be explored in more detail, particularly using larger 
samples of individuals, because it may offer clues on 
the neurobiological bases of these symptoms in particu-
lar and on the etiopathogenesis of bipolar disorder and 
schizophrenia in general. In fact, several Genome Wide 
Association studies (GWAS) have found evidence for a 
common genetic basis for schizophrenia and bipolar dis-
order (Prata et al. 2019). Our results support this hypoth-
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